In the March 14, 2017 Federal Register, the Food and Drug Administration (“FDA”) announced that it is considering establishing a new Office of Patient Affairs (“Office”). This consideration results from FDA’s intention to “enhance future patient engagement by providing a more transparent, accessible, and robust experience for patient communities.”1 The Federal Register notice outlined FDA’s…Read More
FDA Considers Establishing a New Office of Patient Affairs
Posted on May 4, 2017 in Health Law News
Published by: Hall Render